Abstract
Ulcerative colitis and Crohn’s disease represent a disease spectrum with protean manifestations and complications. Although as many as half of all patients with inflammatory bowel disease require at least one surgical procedure to address complications derived from their disease, the decision in favor of a surgical approach and its timing is rarely an easy one. Important considerations entering in the final decision include the localization of the disease, the amount of diseased bowel, the length of grossly normal intestine, the feasibility of bowel-sparing procedures in Crohn’s disease, the likelihood that a temporary or permanent stoma may be necessary and the changes in the quality of life that surgery may produce. Other factors such as personal or work-related commitments may also influence timing of the surgical treatment. Due to the need to balance objective findings with personal considerations, it is essential that the patient, the gastroenterologist and the surgeon, assisted by the radiologist and the pathologist, partake in the decision of the optimal treatment plan for the patient.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Michelassi F, Finco C. Indications for surgery in inflammatory bowel disease: the surgeon’s perspective. Kirsner JB, Shorter RG, eds. Inflammatory Bowel Disease 4th ed. Baltimore: Williams & Wilkins; 1995: 771–783.
Kirsner JB, Palmer WL, Spencer JA, et al. Corti-cotropin (ACTH) and adrenal steroids in the management of ulcerative colitis: observations in 240 patients. Ann Int Med 1959;50:89.
Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis. Gut 1963;4:299.
Korelitz B, Lindner AE. The influence of corti-cotrophin and adrenal steroids in the course of ulcerative colitis: a comparison with the presteroid era. Gastroenterology 1964;46:671.
Meyers S, Sachar DB, Goldberg JD, et al. Corti-cotropin versus hydrocorticosone in the intravenous treatment of ulcerative colitis: prospective, randomized, double-blind clinical trial. Gastroenterology 1983;85:351.
Lichtiger S, Present DH, Kornbluth A, et al. Cyclo-sporin in severe ulcerative colitis refractory to steroid therapy. New Engl J Med 1994;330(26):1841–1845.
Norland C, Kirsner JB. Toxic dilatation of colon (toxic megacolon): etiology, treatment and prognosis in 42 patients. Medicine 1969;48:229.
Ransohoff D. Colon cancer in ulcerative colitis. Gastroenterology 1988;94:1089.
Blackstone MO, Radial RH, Rogers BHG, et al. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology 1981;80:366.
Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis IV. Carcinoma of the colon. Gut 1964;5:15.
Michelassi F, Balestracci T, Chappell R, et al. Primary and recurrent Crohn’s disease: experience with 1379 patients. Ann Surg 1991;214(3):230–240.
Farmer RG, Hawk WA, Turnbull RG Jr. Clinical patterns in Crohn’s disease: statistical study of 615 cases. Gastroenterology 1975;68:627.
Crohn BB, Yarnis H. Regional ileitis. 2nd ed. New York: Grune & Stratton 1958.
Homan WP, Tang CK, Thorbjarnason B. Acute massive hemorrhagae from intestinal Crohn’s disease. Arch Surg 1976;111:901.
Darke SG, Parks AG, Grogono JL, et al Adenocar-cinoma and Crohn’s disease: a report of two cases and analysis of the literature. Br J Surg 1973;60:169–175.
McCafferty TD, Nasr K, Lawrence AM, et al. Severe growth retardation in children with inflammatory bowel disease. Pediatrics 1970;45:386.
Homer DR, Grand RJ, Colodny AH. Growth course and prognosis after surgery for Crohn’s disease in children and adolescents. Pediatrics 1977;59:717.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Michelassi, F. (1999). Indications for Surgical Treatment in Ulcerative Colitis and Crohn’s Disease. In: Michelassi, F., Milsom, J.W. (eds) Operative Strategies in Inflammatory Bowel Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-1396-3_8
Download citation
DOI: https://doi.org/10.1007/978-1-4612-1396-3_8
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-7130-7
Online ISBN: 978-1-4612-1396-3
eBook Packages: Springer Book Archive